Aditi Bapat
Scientist, Discovery Pheast Therapeutics
Dr. Aditi Bapat is a Scientist in Discovery at Pheast Therapeutics, where she investigates novel targets to enhance macrophage-mediated phagocytosis in cancer. She earned her PhD in Pharmacology from the University of Minnesota, where she studied the effects of tumor-targeted therapies on tumor-associated macrophages in triple-negative breast cancer. At Pheast, Dr. Bapat leads early-stage in vitro and in vivo studies supporting target identification, validation, and model development within preclinical oncology research. Her work bridges immuno-oncology discovery with translational model optimization to advance macrophage-based therapeutics.
Seminars
Wednesday 28th January 2026
Fireside Chat: Optimizing Model Selection for Speed, Cost & Translatability to De-Risk Preclinical Development Under Resource Constraints
4:00 pm
- Navigating budget limitations and tight timelines while selecting models with strong translational potential to accelerate preclinical development without compromising predictive accuracy
- Prioritizing model complexity versus practical feasibility across organoids, PDX, and in silico platforms to maximize ROI and clinical relevance within resource-constrained environments
- Implementing tiered model selection strategies that balance throughput, cost-effectiveness, and biological fidelity to de-risk candidates faster while maintaining translational confidence
